Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products: Questions and Answers: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 9, 2025
December 9, 2025
98d122b6-0f73-480f-9605-fbb17a6e6e72
Related Documents
Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products: Questions and Answers
Guidance DocumentOctober 9, 2026Center for Drug Evaluation and Research
Questions and Answers on Biosimilar Development and the BPCI Act: Guidance for Industry
Guidance DocumentMarch 9, 2026Center for Drug Evaluation and Research
Q8, Q9, and Q10 Questions and Answers (R5)
Guidance DocumentMay 29, 2026Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.